Eligibility criteria and contraindications are detailed in the BNF and the relevant SmPCs on the EMC
Semaglutide, while generally cardiac-neutral, can cause mild increases in heart rate in some patients, particularly during dose escalation
There were no differences in age, BMI, gender, HDRS-24 scores before treatment, treatment days and other demographic characteristics between the effective-treatment and ineffective-treatment groups, there was significant difference in the reduction rate of HDRS-24 scores and HDRS-24 scores after treatment between the two groups (Table 2)
[19] Developmentally, reduced lysyl oxidase activity have been implicated in Menkes disease and occipital horn syndrome, two X-linked recessive disorders characterized by a mutation in a gene coding for a protein involved in copper transport
It also helps with blood sugar control in adults with Type 2 Diabetes